We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ONON:NYSEOn Holding AG Analysis

Data as of 2026-04-22 - not real-time

$36.12

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

On Holding AG trades around $36.12, well above its DCF‑derived fair value of $28.87, implying a premium price despite a forward PE of 17.5 versus a trailing PE of 46.3. The stock is currently below its 20‑day ($34.44), 50‑day ($39.71) and 200‑day ($43.88) moving averages, and the 30‑day volatility sits at a lofty 64.8% with a beta of 1.58, underscoring heightened market sensitivity. Technical signals are mixed: the MACD histogram is positive, suggesting short‑term bullish momentum, yet the overall trend is bearish and trading volume has been decreasing, eroding momentum. Fundamental metrics remain strong—revenue grew 22.6% YoY, gross margin is 62.8% and operating cash flow exceeds $350 M—while the balance sheet shows ample cash ($1.06 B) against modest debt ($0.52 B). Analyst sentiment is largely positive, with a consensus “Buy” rating and a median price target of $56.12, indicating potential upside of roughly 55% from current levels. However, recent coverage notes a ~30% YTD sell‑off and Evercore’s revised target down to $45, highlighting near‑term price pressure. The fear‑greed index at 86.7 (“Extreme Greed”) suggests market optimism may be overstated given the stock’s overvaluation relative to intrinsic estimates. In this context, the short‑term outlook is cautious, while medium‑term prospects hinge on sustaining growth and narrowing the valuation gap. Long‑term, the brand’s global expansion and strong cash generation could justify a re‑rating if pricing aligns with fundamentals. Investors should weigh the premium valuation against the company’s growth trajectory and elevated volatility. Overall, the stock presents a nuanced risk‑reward profile that favors disciplined positioning.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish technical trend (price below all major SMAs)
  • Decreasing volume indicating weakening momentum
  • Current price premium to DCF fair value

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong revenue growth and high gross margin
  • Forward PE compression to 17.5 suggesting valuation improvement
  • Analyst consensus buy and sizable upside target

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • Robust cash generation and low leverage
  • Global brand expansion and direct‑to‑consumer strategy
  • Potential for valuation convergence as growth sustains

Key Metrics & Analysis

Financial Health

Revenue Growth22.60%
Profit Margin6.76%
P/E Ratio46.3
ROE13.47%
ROA9.03%
Debt/Equity31.95
P/B Ratio5.7
Op. Cash Flow$359.5M
Free Cash Flow$264.3M

Technical Analysis

TrendBearish
RSI48.3
Support$31.41
Resistance$37.89
MA 20$34.44
MA 50$39.71
MA 200$43.88
MACDBullish
VolumeDecreasing
Fear & Greed Index86.73

Valuation

Fair Value$28.87
Target Price$56.44
Upside/Downside56.29%
GradeFair
TypeGrowth

Risk Assessment

Beta1.58
Volatility64.82%
Sector RiskHigh
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.